Ovarian cancer: can we reverse drug resistance?
作者： David S. P. Tan , Joo Ern Ang , Stan B. Kaye
DOI: 10.1007/978-0-387-68969-2_13
关键词:
摘要:
springer.com
sci-hub.se 参考文章(91)
Andrew Tutt, Alan Ashworth, The relationship between the roles of BRCA genes in DNA repair and cancer predisposition Trends in Molecular Medicine. ,vol. 8, pp. 571- 576 ,(2002) , 10.1016/S1471-4914(02)02434-6
Eric K. Rowinsky, Martin J. Citardi, Dennis A. Noe, Ross C. Donehower, Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine Journal of Cancer Research and Clinical Oncology. ,vol. 119, pp. 727- 733 ,(1993) , 10.1007/BF01195344
Kenneth D Tew, TLK-286: a novel glutathione S-transferase-activated prodrug. Expert Opinion on Investigational Drugs. ,vol. 14, pp. 1047- 1054 ,(2005) , 10.1517/13543784.14.8.1047
J B Easton, P J Houghton, mTOR and cancer therapy. Oncogene. ,vol. 25, pp. 6436- 6446 ,(2006) , 10.1038/SJ.ONC.1209886
Udai Banerji, Michael Walton, Florence Raynaud, Rachel Grimshaw, Lloyd Kelland, Melani Valenti, Ian Judson, Paul Workman, Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models. Clinical Cancer Research. ,vol. 11, pp. 7023- 7032 ,(2005) , 10.1158/1078-0432.CCR-05-0518
Ronald Simon, Guido Sauter, Tissue microarray (TMA) applications: implications for molecular medicine. Expert Reviews in Molecular Medicine. ,vol. 5, pp. 1- 12 ,(2003) , 10.1017/S1462399403006781
Cheryl A. Sherman-Baust, Ashani T. Weeraratna, Leticia B.A. Rangel, Ellen S. Pizer, Kathleen R. Cho, Donald R. Schwartz, Teresa Shock, Patrice J. Morin, Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells Cancer Cell. ,vol. 3, pp. 377- 386 ,(2003) , 10.1016/S1535-6108(03)00058-8
Gerard J Mulder, Sivi Ouwerkerk-Mahadevan, Modulation of glutathione conjugation in vivo: how to decrease glutathione conjugation in vivo or in intact cellular systems in vitro. Chemico-Biological Interactions. ,vol. 105, pp. 17- 34 ,(1997) , 10.1016/S0009-2797(97)00038-0
P.H.J. Houba, E. Boven, I.H. van der Meulen-Muileman, R.G.G. Leenders, J.W. Scheeren, H.M. Pinedo, H.J. Haisma, Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugate International Journal of Cancer. ,vol. 91, pp. 550- 554 ,(2001) , 10.1002/1097-0215(200002)9999:9999<::AID-IJC1075>3.0.CO;2-L
Dao M Nguyen, Dominique Lorang, G.Aaron Chen, John H Stewart, Esmail Tabibi, David S Schrump, Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis The Annals of Thoracic Surgery. ,vol. 72, pp. 371- 379 ,(2001) , 10.1016/S0003-4975(01)02787-4